APA

Martín I., Navarro B., Villamón E., Solano C., Serrano A., Calabuig M., Amat P., Domingo F., Abellán R., García F., Olivares M. D., Chaves F. J., Tormo M. & Hernández-Boluda J. C. (20181127). Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin. : Experimental and molecular pathology.

Chicago

Martín Iván, Navarro Blanca, Villamón Eva, Solano Carlos, Serrano Alicia, Calabuig Marisa, Amat Paula, Domingo Fernando, Abellán Rosario, García Francisca, Olivares María Dolores, Chaves Francisco Javier, Tormo Mar and Hernández-Boluda Juan Carlos. 20181127. Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin. : Experimental and molecular pathology.

Harvard

Martín I., Navarro B., Villamón E., Solano C., Serrano A., Calabuig M., Amat P., Domingo F., Abellán R., García F., Olivares M. D., Chaves F. J., Tormo M. and Hernández-Boluda J. C. (20181127). Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin. : Experimental and molecular pathology.

MLA

Martín Iván, Navarro Blanca, Villamón Eva, Solano Carlos, Serrano Alicia, Calabuig Marisa, Amat Paula, Domingo Fernando, Abellán Rosario, García Francisca, Olivares María Dolores, Chaves Francisco Javier, Tormo Mar and Hernández-Boluda Juan Carlos. Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin. : Experimental and molecular pathology. 20181127.